Rare Disease Innovation and Partnering Summit 2020

Rare Disease Innovation and Partnering Summit 2020
December 1-4, 2020 | Virtual Event
www.raredisease-summit.com

This December, tackle challenges faced in ensuring patient access and furthering therapeutic and curative progress at the Rare Disease Innovation & Partnering Summit. Held in a 100% virtual format, this four-day meeting convenes diverse stakeholders to discuss opportunities for continued innovation, advancement of impactful patient advocacy and acceleration of commercial strategy success. Benefit from live sessions, keynotes and panels, plus a library of on-demand sessions ready to watch as your schedule allows. All sessions are available for viewing for 30 days post event.

Visit www.raredisease-summit.com for further details and to register. Drug Channels readers will save $200 off the standard rate when they use code ZZX688 and register prior to November 13th.*

You can download the complete agenda here.

Unparalleled Insights, Impactful Keynotes and Luminary Addresses from Industry Trailblazers, including:

• Patient Perspective - Chasing My Cure
  David Fajgenbaum, M.D., Co-founder and Executive Director, CASTLEMAN DISEASE COLLABORATIVE NETWORK

• Technology Spotlight - Using AI to Speed Discovery and New Treatments
  Tim Guilliams, Founder, CEO, HEALX LTD

• Scientific Luminary - Targeting the Morphological Impact of Disease
  Marzieh Haghighi, PH.D., Postdoctoral Associate, BROAD INSTITUTE OF HARVARD MIT

• Novel Funding - Accelerate Rare Disease Therapeutic Development
  Andrew Lo, Ph.D., Charles E. and Susan T. Harris Professor, MIT SLOAN SCHOOL OF MANAGEMENT

• FDA Address – Navigating Regulatory Pathways and Evidentiary Requirements
  Kerry Jo Lee, MD, Acting Associate Director for Rare Diseases, FDA/CDER/OND

PLUS! Hear from the most innovative industry organizations, including Acceleron, Alexion, Alkeus Pharmaceuticals, Argenx, Biogen, Castle Creek Biosciences, Centogene, Collaborations Pharmaceuticals, Foundation Medicine, Perseo Pharma, Relypsa, Sanofi Genzyme and more.

Customize Your Virtual Experience with Powerful Program Offerings:

• Two Strategic, One-Day Forums:
• Global Drug Development and Access
• Patient Engagement, Advocacy and Alliance Management

• Four Targeted Track Offerings:
• Patient-Driven Progress
• Reimbursement, Value and Access
• New Launch and Commercialization
• Partnering, Investment and Portfolio Strategy

Download the agenda to plan your sessions and wrap up your week armed with critical updates and valuable takeaways.

Visit www.raredisease-summit.com for further details and to register. Drug Channels readers will save $200 off the standard rate when they use code ZZX688 and register prior to November 13th.*

Informa Connect-CBI will see you there!

*Cannot be combined with other offers or used towards a current registration. Cannot be combined with special category rates, clinic/hospital rates, non-profit/advocacy rates or other offers. Other restrictions may apply.

---

The content of Sponsored Posts does not necessarily reflect the views of Pembroke Consulting, Inc., Drug Channels, or any of its employees.